Regend Therapeutics
Clinical trials sponsored by Regend Therapeutics, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Stem cell trial aims to regrow lungs in COPD patients Results expected Oct 2026 (estimated)
- Stem cells injected for lung scarring: early trial begins Results expected Feb 2027 (estimated)